Help | RSS Feed

Clinuvel Pharmaceuticals Ltd. (OTCMKT:CLVLY) Seasonal Chart

CLVLY Relative to the S&P 500
CLVLY Relative to the S&P 500

CLVLY Relative to the Sector
CLVLY Relative to the Sector

Monthly Seasonal Clinuvel Pharmaceuticals Ltd. (OTCMKT:CLVLY)

Seasonal Chart Analysis

Analysis of the Clinuvel Pharmaceuticals Ltd. (OTCMKT:CLVLY) seasonal charts above shows that a Buy Date of October 8 and a Sell Date of January 22 has resulted in a geometric average return of 9.38% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 12.77% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders.

To download CLVLY seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z